Quick Takeaways
- SUVRETTA CAPITAL MANAGEMENT, LLC filed SCHEDULE 13G/A for Kura Oncology, Inc. Common Stock, par value $0.0001 per share (KURA).
- Disclosed ownership: 9.4%.
- Date of event: 31 Mar 2025.
SUVRETTA CAPITAL MANAGEMENT, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Kura Oncology, Inc. Common Stock, par value $0.0001 per share (KURA)
- Filing Manager
- SUVRETTA CAPITAL MANAGEMENT, LLC
- Reporting Manager
- SUVRETTA CAPITAL MANAGEMENT, LLC
- Symbol
- KURA
- Shares outstanding
- 80,436,170 shares
- Disclosed Ownership
- 7,561,000 shares
- Ownership
- 9.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 02 May 2025, 17:16:46 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 13 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"SUVRETTA CAPITAL MANAGEMENT, LLC disclosed 9.4% ownership in Kura Oncology, Inc. Common Stock, par value $0.0001 per share (KURA) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 13 Feb 2025.
- Current filing was accepted on 02 May 2025, 17:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.4% | 7,561,000 | 0 | 7,561,000 | By: /s/ Andrew Nathanson | Andrew Nathanson / General Counsel and Chief Compliance Officer | |
| AVERILL MASTER FUND, LTD. | 8.6% | 6,922,080 | 0 | 6,922,080 | By: /s/ Andrew Nathanson | Andrew Nathanson / Authorized Signatory | |
| AARON COWEN | 9.4% | 7,561,000 | 0 | 7,561,000 | By: /s/ Aaron Cowen | Aaron Cowen |